XS Financial Provides $7.6MM in Capex Financing to PharmaCann

XS Financial, a specialty finance company that provides capex and equipment financing solutions to cannabis companies in the U.S., entered into a new lease with PharmaCann for $7.6 million.

PharmaCann continues to deploy resources from its pre-existing $30 million facility, which was announced Dec. 11, 2022, leveraging available capital to further drive growth within its business.

“We highly value our long-term relationship with XS Financial as a financing partner for our strategic capital needs,” Patrick Unzicker, CFO of PharmaCann, said. “This transaction provides funding to support PharmaCann growth plans in our eight-state footprint.”

“We are thrilled to announce the successful closing of a new lease transaction with our esteemed, long-standing client, Pharmacann,” Antony Radbod, COO of XS Financial, said. “This latest round of financing is a testament to XS Financials’ commitment to the cannabis industry and reaffirms our steadfast dedication to the broader market. Amid the current capital-constrained climate, this transaction underscores our unwavering commitment to supporting top-tier operators in the cannabis industry.”

Like this story? Begin each business day with news you need to know! Click here to register now for our FREE Daily E-News Broadcast and start YOUR day informed!

Leave a comment

View Latest Digital Edition

Terry Mulreany
Subscriptions: 800 708 9373 x130
[email protected]
Susie Angelucci
Advertising: 484.459.3016
[email protected]

View Latest Digital Edition

Visit our sister website for news, information, exclusive articles,
deal tables and more on the asset-based lending, factoring,
and restructuring industries.